• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

溴隐亭可减小分泌催乳素的垂体腺瘤中的细胞大小。

Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.

作者信息

Landolt A M, Minder H, Osterwalder V, Landolt T A

出版信息

Experientia. 1983 Jun 15;39(6):625-6. doi: 10.1007/BF01971131.

DOI:10.1007/BF01971131
PMID:6852202
Abstract

The morphometric analysis of the size of adenomatous prolactin cells shows that bromocriptine-induced cell shrinkage halts if treatment with the drug is discontinued for more than 2 days. Different cell components (nucleus, cytoplasm, nucleolus) do not react to treatment to the same extent.

摘要

对腺瘤性催乳素细胞大小的形态计量分析表明，如果停用溴隐亭治疗超过2天，该药诱导的细胞萎缩就会停止。不同的细胞成分（细胞核、细胞质、核仁）对治疗的反应程度不同。

相似文献

1
Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.溴隐亭可减小分泌催乳素的垂体腺瘤中的细胞大小。
Experientia. 1983 Jun 15;39(6):625-6. doi: 10.1007/BF01971131.
2
Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis.溴隐亭对分泌催乳素的垂体腺瘤的作用。通过光镜、电镜、免疫组化及形态计量分析评估肿瘤体积缩小的机制。
Cancer. 1985 Jul 15;56(2):230-8. doi: 10.1002/1097-0142(19850715)56:2<230::aid-cncr2820560204>3.0.co;2-8.
3
Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.溴隐亭治疗后泌乳素分泌型垂体腺瘤氨基酸代谢的快速下降：一项PET研究
J Comput Assist Tomogr. 1987 Sep-Oct;11(5):815-9. doi: 10.1097/00004728-198709000-00014.
4
Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.溴隐亭治疗分泌催乳素的垂体腺瘤可能恢复垂体功能。
Ann Intern Med. 1984 Dec;101(6):783-5. doi: 10.7326/0003-4819-101-6-783.
5
Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.溴隐亭对催乳素分泌性腺瘤的影响：CT扫描分析
Comput Radiol. 1983 Jul-Aug;7(4):237-41. doi: 10.1016/0730-4862(83)90148-8.
6
Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.溴隐亭治疗期间分泌催乳素的垂体微腺瘤增大。病例报告。
Br J Obstet Gynaecol. 1982 Feb;89(2):169-70. doi: 10.1111/j.1471-0528.1982.tb04688.x.
7
Clinical and morphological findings in two cases of bromocriptine-treated prolactinomas.两例经溴隐亭治疗的催乳素瘤的临床及形态学表现
Acta Pathol Microbiol Scand A. 1981 Jan;89(1):41-7. doi: 10.1111/j.1699-0463.1981.tb00185.x.
8
Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.侵袭性混合生长激素/催乳素分泌型垂体瘤：经奥曲肽和溴隐亭治疗后肿瘤完全缩小，停用奥曲肽20个月后肿瘤无生长复发。
Acta Endocrinol (Copenh). 1992 Feb;126(2):179-83. doi: 10.1530/acta.0.1260179.
9
Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.溴隐亭治疗后鞍外分泌催乳素的垂体大腺瘤缩小后的妊娠情况。
Obstet Gynecol. 1984 Sep;64(3 Suppl):2S-7S. doi: 10.1097/00006250-198409001-00001.
10
Bromocriptine-induced changes in hormone secretion and cell morphology in growth hormone and prolactin producing pituitary adenomas.溴隐亭对生长激素及泌乳素分泌型垂体腺瘤激素分泌和细胞形态的影响
Acta Otolaryngol. 1981 Sep-Oct;92(3-4):343-55. doi: 10.3109/00016488109133271.

引用本文的文献

1
Effects of preoperative bromocriptine treatment on prolactin-secreting pituitary adenoma surgery.术前溴隐亭治疗对泌乳素分泌型垂体腺瘤手术的影响。
Exp Ther Med. 2016 May;11(5):1977-1982. doi: 10.3892/etm.2016.3122. Epub 2016 Mar 2.
2
Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.使用卡麦角林治疗囊性大泌乳素瘤期间发生垂体卒中。
Pituitary. 2008;11(3):287-92. doi: 10.1007/s11102-007-0046-6.
3
Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI).

本文引用的文献

1
Cerebrospinal fluid rhinorrhea: a complication of therapy for invasive prolactinomas.脑脊液鼻漏：侵袭性催乳素瘤治疗的一种并发症。
Neurosurgery. 1982 Sep;11(3):395-401. doi: 10.1227/00006123-198209000-00010.
2
Structural changes in human pituitary tumor after bromocriptine therapy.溴隐亭治疗后人类垂体肿瘤的结构变化。
Neurosurgery. 1982 Feb;10(2):242-51.
3
Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells.多巴胺能抑制培养垂体细胞中催乳素的合成及催乳素信使核糖核酸的积累。
通过动态对比增强磁共振成像（DCE-MRI）评估多巴胺激动剂对催乳素瘤和正常垂体的影响。
Pituitary. 2007;10(3):261-6. doi: 10.1007/s11102-007-0048-4.
4
Diagnosis and drug therapy of prolactinoma.泌乳素瘤的诊断与药物治疗
Drugs. 1996 Jun;51(6):954-65. doi: 10.2165/00003495-199651060-00004.
5
Topical effect of bromocriptine on rat-transplanted human prolactinomas.
Acta Neurochir (Wien). 1993;120(3-4):175-9. doi: 10.1007/BF02112038.
6
Bromocriptine-induced removal of endoplasmic membranes from prolactinoma cells.溴隐亭诱导催乳素瘤细胞内质网膜的去除。
Experientia. 1985 May 15;41(5):640-2. doi: 10.1007/BF02007698.
7
Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.溴隐亭对老年Long-Evans大鼠自发性垂体催乳素细胞增生的形态学影响。
Am J Pathol. 1986 Jan;122(1):7-16.
8
Pituitary adenomas in patients under 20 years old. A clinicopathological study of 12 cases.
J Neurooncol. 1986;4(1):79-89. doi: 10.1007/BF02158007.
J Biol Chem. 1980 Sep 10;255(17):8092-7.
4
Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP.麦角隐亭和环磷酸腺苷对催乳素基因的转录调控
Nature. 1981 Nov 5;294(5836):94-7. doi: 10.1038/294094a0.
5
Practical stereological methods for morphometric cytology.形态计量细胞学的实用体视学方法。
J Cell Biol. 1966 Jul;30(1):23-38. doi: 10.1083/jcb.30.1.23.
6
Ergot-induced inhibition of pituitary tumor growth in rats.麦角诱导的大鼠垂体肿瘤生长抑制
Science. 1972 Apr 28;176(4033):417-8. doi: 10.1126/science.176.4033.417.
7
Direct antiproliferative effect of dopamine agonists on the anterior pituitary gland in organ culture.
J Endocrinol. 1978 Nov;79(2):245-6. doi: 10.1677/joe.0.0790245.